Start Date
December 12, 2019
Primary Completion Date
June 12, 2020
Study Completion Date
June 12, 2020
IV Nivolumab
240mg every 2 weeks.
IV Nivolumab
Initial treatment dose is 240mg every 2 weeks for 4 doses. Dose changes to 360mg every 3 weeks when given with GDP/L-aspa. Maintenance treatment dose is 240mg every 2 weeks.
IV Gemcitabine
800mg/m2 on Days 1 and 8 every 21 days
IV Cisplatin
20mg/m2 on Day 1 to 4 every 21 days
IV/PO Dexamethasone
10mg on Days 1 to 4 every 21 days
IV L-asparaginase
6000 Units/m2 on Days 2 to 8 every 21 days
National Cancer Centre Singapore, Singapore
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
National Cancer Centre, Singapore
OTHER